212 related articles for article (PubMed ID: 2397001)
1. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Dei Cas L; Metra M; Nodari S; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Sannia L; Ibba GV; Castellaccio M; Dore L
Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
Gavazzi A; Mussini A; Bramucci E
Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
[TBL] [Abstract][Full Text] [Related]
5. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure.
Leier CV; Ren JH; Huss P; Unverferth DV
Pharmacotherapy; 1986; 6(1):35-40. PubMed ID: 3952005
[TBL] [Abstract][Full Text] [Related]
6. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
[TBL] [Abstract][Full Text] [Related]
7. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K
Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
[TBL] [Abstract][Full Text] [Related]
8. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
[TBL] [Abstract][Full Text] [Related]
12. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
Humar F; Morgera T; Maras P; Camerini F
Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy.
Ramakrishnan S; Malik V; Karthikeyan G; Seth S; Yadav R; Singh S; Deepak KK; Bhargava B
Indian Heart J; 2008; 60(6):599-601. PubMed ID: 19276506
[TBL] [Abstract][Full Text] [Related]
15. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic response to ibopamine in acute myocardial infarction.
Taniguchi H; Iwasaka T; Sugiura T; Takayama Y; Sumimoto T; Onoyama H; Takashima H; Nakamura S; Inada M
Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
[TBL] [Abstract][Full Text] [Related]
17. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C
Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
[TBL] [Abstract][Full Text] [Related]
18. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
Benassi A; Modena MG; Mattioli G
Arzneimittelforschung; 1986 Feb; 36(2A):390-4. PubMed ID: 3518726
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
